vs
雅培（ABT）与NATURAL HEALTH TRENDS CORP（NHTC）财务数据对比。点击上方公司名可切换其他公司
雅培的季度营收约是NATURAL HEALTH TRENDS CORP的1175.4倍（$11.5B vs $9.7M）。雅培净利率更高（15.5% vs -6.0%，领先21.5%）。雅培同比增速更快（4.4% vs -10.1%）。雅培自由现金流更多（$2.6B vs $-964.0K）。过去两年雅培的营收复合增速更高（7.2% vs -5.6%）
雅培是总部位于美国伊利诺伊州雅培园的跨国医疗健康企业，业务覆盖美国境外市场药品销售、诊断产品、营养产品及医疗器械等板块，在全球医疗健康领域拥有较高的行业知名度与广泛的市场覆盖。
Sword Health是一家数字医疗企业，专注开发针对肌肉骨骼疾病、骨盆健康与损伤预防的物理治疗方案。该企业2015年由Virgílio Bento与Márcio Colunas在葡萄牙创立，将人工智能融入护理模式，提供数字化物理治疗服务。截至2024年，Sword Health已开展国际化运营，在美国、爱尔兰与葡萄牙均设有办公室。
ABT vs NHTC — 直观对比
营收规模更大
ABT
是对方的1175.4倍
$9.7M
营收增速更快
ABT
高出14.5%
-10.1%
净利率更高
ABT
高出21.5%
-6.0%
自由现金流更多
ABT
多$2.6B
$-964.0K
两年增速更快
ABT
近两年复合增速
-5.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $11.5B | $9.7M |
| 净利润 | $1.8B | $-588.0K |
| 毛利率 | 57.0% | 72.9% |
| 营业利润率 | 19.6% | -6.5% |
| 净利率 | 15.5% | -6.0% |
| 营收同比 | 4.4% | -10.1% |
| 净利润同比 | -80.8% | -434.1% |
| 每股收益（稀释后） | $1.01 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABTNHTC
| Q4 25 | $11.5B | $9.7M | ||
| Q3 25 | $11.4B | $9.5M | ||
| Q2 25 | $11.1B | $9.8M | ||
| Q1 25 | $10.4B | $10.7M | ||
| Q4 24 | $11.0B | $10.8M | ||
| Q3 24 | $10.6B | $10.7M | ||
| Q2 24 | $10.4B | $10.5M | ||
| Q1 24 | $10.0B | $11.0M |
净利润ABTNHTC
| Q4 25 | $1.8B | $-588.0K | ||
| Q3 25 | $1.6B | $-431.0K | ||
| Q2 25 | $1.8B | $15.0K | ||
| Q1 25 | $1.3B | $122.0K | ||
| Q4 24 | $9.2B | $176.0K | ||
| Q3 24 | $1.6B | $35.0K | ||
| Q2 24 | $1.3B | $173.0K | ||
| Q1 24 | $1.2B | $188.0K |
毛利率ABTNHTC
| Q4 25 | 57.0% | 72.9% | ||
| Q3 25 | 55.4% | 73.7% | ||
| Q2 25 | 56.4% | 73.9% | ||
| Q1 25 | 56.9% | 73.6% | ||
| Q4 24 | 55.0% | 74.2% | ||
| Q3 24 | 55.8% | 74.1% | ||
| Q2 24 | 55.6% | 74.2% | ||
| Q1 24 | 55.2% | 73.4% |
营业利润率ABTNHTC
| Q4 25 | 19.6% | -6.5% | ||
| Q3 25 | 18.1% | -5.2% | ||
| Q2 25 | 18.4% | -3.4% | ||
| Q1 25 | 16.3% | -3.2% | ||
| Q4 24 | 17.4% | -3.9% | ||
| Q3 24 | 17.5% | -2.6% | ||
| Q2 24 | 16.1% | -2.3% | ||
| Q1 24 | 13.9% | -3.3% |
净利率ABTNHTC
| Q4 25 | 15.5% | -6.0% | ||
| Q3 25 | 14.5% | -4.5% | ||
| Q2 25 | 16.0% | 0.2% | ||
| Q1 25 | 12.8% | 1.1% | ||
| Q4 24 | 84.1% | 1.6% | ||
| Q3 24 | 15.5% | 0.3% | ||
| Q2 24 | 12.5% | 1.7% | ||
| Q1 24 | 12.3% | 1.7% |
每股收益（稀释后）ABTNHTC
| Q4 25 | $1.01 | $-0.05 | ||
| Q3 25 | $0.94 | $-0.04 | ||
| Q2 25 | $1.01 | $0.00 | ||
| Q1 25 | $0.76 | $0.01 | ||
| Q4 24 | $5.26 | $0.01 | ||
| Q3 24 | $0.94 | $0.00 | ||
| Q2 24 | $0.74 | $0.02 | ||
| Q1 24 | $0.70 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.9B | $28.9M |
| 总债务越低越好 | $12.9B | — |
| 股东权益账面价值 | $52.1B | $23.4M |
| 总资产 | $86.7B | $38.4M |
| 负债/权益比越低杠杆越低 | 0.25× | — |
8季度趋势，按日历期对齐
现金及短期投资ABTNHTC
| Q4 25 | $8.9B | $28.9M | ||
| Q3 25 | $7.7B | $32.0M | ||
| Q2 25 | $7.3B | $34.2M | ||
| Q1 25 | $6.8B | $41.9M | ||
| Q4 24 | $8.0B | $43.9M | ||
| Q3 24 | $7.8B | $46.3M | ||
| Q2 24 | $7.2B | $48.7M | ||
| Q1 24 | $6.7B | $54.4M |
总债务ABTNHTC
| Q4 25 | $12.9B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $14.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ABTNHTC
| Q4 25 | $52.1B | $23.4M | ||
| Q3 25 | $51.0B | $26.1M | ||
| Q2 25 | $50.6B | $28.9M | ||
| Q1 25 | $48.8B | $30.9M | ||
| Q4 24 | $47.7B | $32.9M | ||
| Q3 24 | $39.8B | $35.3M | ||
| Q2 24 | $39.3B | $37.3M | ||
| Q1 24 | $38.8B | $39.4M |
总资产ABTNHTC
| Q4 25 | $86.7B | $38.4M | ||
| Q3 25 | $84.2B | $42.3M | ||
| Q2 25 | $84.0B | $45.2M | ||
| Q1 25 | $81.4B | $53.2M | ||
| Q4 24 | $81.4B | $55.4M | ||
| Q3 24 | $74.4B | $58.3M | ||
| Q2 24 | $73.0B | $61.5M | ||
| Q1 24 | $72.5B | $67.6M |
负债/权益比ABTNHTC
| Q4 25 | 0.25× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.30× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.3B | $-959.0K |
| 自由现金流经营现金流 - 资本支出 | $2.6B | $-964.0K |
| 自由现金流率自由现金流/营收 | 22.9% | -9.9% |
| 资本支出强度资本支出/营收 | 6.0% | 0.1% |
| 现金转化率经营现金流/净利润 | 1.87× | — |
| 过去12个月自由现金流最近4个季度 | $7.4B | $-6.1M |
8季度趋势，按日历期对齐
经营现金流ABTNHTC
| Q4 25 | $3.3B | $-959.0K | ||
| Q3 25 | $2.8B | $113.0K | ||
| Q2 25 | $2.0B | $-5.6M | ||
| Q1 25 | $1.4B | $484.0K | ||
| Q4 24 | $2.9B | $88.0K | ||
| Q3 24 | $2.7B | $-436.0K | ||
| Q2 24 | $2.0B | $-3.6M | ||
| Q1 24 | $1.0B | $549.0K |
自由现金流ABTNHTC
| Q4 25 | $2.6B | $-964.0K | ||
| Q3 25 | $2.3B | $70.0K | ||
| Q2 25 | $1.5B | $-5.6M | ||
| Q1 25 | $933.0M | $468.0K | ||
| Q4 24 | $2.1B | $68.0K | ||
| Q3 24 | $2.1B | $-443.0K | ||
| Q2 24 | $1.4B | $-3.6M | ||
| Q1 24 | $627.0M | $538.0K |
自由现金流率ABTNHTC
| Q4 25 | 22.9% | -9.9% | ||
| Q3 25 | 20.2% | 0.7% | ||
| Q2 25 | 13.9% | -57.5% | ||
| Q1 25 | 9.0% | 4.4% | ||
| Q4 24 | 19.6% | 0.6% | ||
| Q3 24 | 20.2% | -4.1% | ||
| Q2 24 | 13.8% | -34.2% | ||
| Q1 24 | 6.3% | 4.9% |
资本支出强度ABTNHTC
| Q4 25 | 6.0% | 0.1% | ||
| Q3 25 | 4.4% | 0.5% | ||
| Q2 25 | 4.5% | 0.0% | ||
| Q1 25 | 4.7% | 0.1% | ||
| Q4 24 | 6.6% | 0.2% | ||
| Q3 24 | 5.2% | 0.1% | ||
| Q2 24 | 5.1% | 0.2% | ||
| Q1 24 | 4.0% | 0.1% |
现金转化率ABTNHTC
| Q4 25 | 1.87× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.15× | -375.67× | ||
| Q1 25 | 1.07× | 3.97× | ||
| Q4 24 | 0.31× | 0.50× | ||
| Q3 24 | 1.64× | -12.46× | ||
| Q2 24 | 1.51× | -20.62× | ||
| Q1 24 | 0.84× | 2.92× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
